Cholangiocarcinoma in Young Individuals with and Without Primary Sclerosing Cholangitis.
From: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
The American journal of gastroenterology
- Publish Date: Aug 2007
- ISSN: 0002-9270
- Volume: 102
- Issue: 8
- Pages: 1677-82
- Medium: Print
- Language: English
- Citation (JAMA): Björnsson Einar, Angulo Paul, et al. Cholangiocarcinoma in Young Individuals with and Without Primary Sclerosing Cholangitis.. Am. J. Gastroenterol. Aug 2007;102:1677-82
Abstract
OBJECTIVES: We aimed at characterizing the clinical presentation and prognosis of cholangiocarcinoma in youth with and without primary sclerosing cholangitis (PSC). METHODS: Thirteen patients < or =25 yr of age with cholangiocarcinoma with or without PSC seen at the Mayo Clinic in Rochester, MN from 1980 to 2005 were identified. RESULTS: Of the 13 patients with cholangiocarcinoma, 8 had concomitant PSC and 5 did not. PSC was the associated risk factor in 8/13 (61.5%) whereas PSC was present in only 321/2,014 (15.9%) cases with cholangiocarcinoma in patients older than 25 (P < 0.0001) seen in the same period of time. Seven of the eight (88%) patients with cholangiocarcinoma and PSC had IBD and 5 of the 7 (71%) had Crohn’s disease. A mean 11 months transplant free survival was observed (range 3-20 months) in cholangiocarcinoma with PSC versus 8 months in cholangiocarcinoma patients without PSC (NS). CONCLUSIONS: Cholangiocarcinoma is a rare disorder in young adults and it seems not to exist in children. The youth group of cholangiocarcinoma plus PSC seems to have a higher prevalence of Crohn’s disease whereas the prognosis of cholangiocarcinoma in youth seems to be similarly poor as described in older patients with cholangiocarcinoma.
Mesh Headings (Keywords): Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Cholangiocarcinoma, Cholangitis, Sclerosing, Crohn Disease, Female, Humans, Liver Transplantation, Male, Prognosis, Risk Factors
Check for Full Text / PubMed Unique Identifier (PMID): 17433022
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.